SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix Inc. (NASDAQ:AFFX) announced today that scientists working on the International Genome Structural Variation Consortium’s Copy Number Variation Project have used the 500K Array to help generate the first comprehensive copy number variation (CNV) map of the human genome. The team discovered hundreds of CNVs that will enable researchers to perform more powerful association studies on diseases such as cancer, Parkinson’s and Alzheimer’s. The results of this study have been published in the November 23, 2006 issue of Nature1 along with a supporting paper in Genome Research2.
